Prospective cohort study of HCV infection and the risk of developement of maligant lymphoma

Prospective cohort study of HCV infection and the risk of developement of maligant lymphoma - HCV infection and malignant lymphoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003652

Enrollment

2000

Registered

2010-06-01

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematopoietic malignancy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All cases who are newly diagnosed as malignant lymphomam, acute leukemia, plasma cell dyscrasia, myeloproliferative disorders, and myelodysplastic syndrome from July 2009.

Exclusion criteria

Exclusion criteria: not specified

Design outcomes

Primary

Measure	Time frame
The difference of the ratio of HCV infected population between malignant lymphoma and other hematopoietic malignancies.	—

Secondary

Measure	Time frame
The difference of HCV genotype between malignant lymphoma and other hematopoietic malignancies.	—

Countries

Japan

Contacts

Public ContactHirokazu Nagai

National Hospital Organization Nagoya Medical Center Clinical Research Center

nagaih@nnh.hosp.go.jp052-951-1111

Outcome results